KORELASI INDEKS PLATELET DAN KADAR INTERLEUKIN-6 PADA PASIEN HIPERTENSI

  • Rini Roslaeni Departemen Patologi Klinik, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Hendri Priyadi Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Hindun Sa'adah Departemen Anatomi, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Linlin Haeni Departemen Histologi, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Desy Linasari Departemen Ilmu Kesehatan Masyarakat, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Laila Hasanah Program Studi Kedokteran, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Salma Syifa Salsabila Program Studi Kedokteran, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Rifat Budi Augustyo Isnaeni Program Studi Kedokteran, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia
  • Dika Kusuma Putra Program Studi Kedokteran, Fakultas Kedokteran Universitas Jenderal Achmad Yani, Cimahi, Jawa Barat, Indonesia

Abstract

Mekanisme terjadinya hipertensi melibatkan proses inflamasi dan aktivasi sistem imun yang membentuk kondisi proinflamasi dan protrombotik, ditandai pelepasan reactive oxygen species (ROS). Kondisi tersebut menyebabkan disfungsi endotel, aterosklerosis dan pelepasan interleukin-6 (IL-6) yang pada akhirnya mempengaruhi fungsi platelet. Indeks platelet yang terdiri dari Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), Platelet Large Cell Ratio (PLCR), dan Plateletcrit (PCT) dapat menjadi penanda aktivasi platelet dan inflamasi. Disisi lain, IL-6 juga merupakan sitokin inflamasi ang terlibat dalam berbagai penyakit. Tetapi, korelasi antara kedua parameter ini masih belum sepenuhnya dipahami. Penelitian ini bertujuan untuk mengetahui korelasi antara indeks platelet  dan kadar IL-6 pada pasien hipertensi. Subjek penelitian berjumlah 42 orang penderita hipertensi tanpa komplikasi. Pemeriksaan indeks platelet menggunakan alat hematology analyzer Maccura 560 Plus, sedangkan pemeriksaan IL-6 menggunakan mikroelisa. Hasil menunjukkan usia subjek rerata 57,8 ± 9,9 tahun, dan mayoritas perempuan 81%. Rerata sistolik 145,26 ± 15,02 mmHg dan diastolik 87,69 ± 11,55 mmHg. Rerata subjek lama menderita hipertensi 5,53 ± 4,24 tahun.  Rerata MPV 7,7 ± 0,7 fL, PDW 13,1 ± 1,73 fl, PCT 0,24 ± 0,05%, dan P-LCR 21,6 ± 5,59%. Kadar IL-6 rerata adalah 23,28 ± 2,70 pg/mL.  Tidak ditemukan korelasi signifikan antara indeks platelet dan kadar IL-6. Temuan ini mengindikasikan bahwa parameter-parameter tersebut mungkin tidak relevan dalam menggambarkan status inflamasi yang diwakili oleh kadar IL-6 dan indeks platelet pada populasi ini.


 


Kata Kunci: Hipertensi, Indeks platelet, Interleukin-6, MPV, PDW, PCT, P-LCR


DOI : 10.35990/mk.v8n1.p71-81

References

1. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nat Rev Desease Prim. 2018;4(18014):1–48.
2. Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, et al. Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? Int J Hypertens. 2019;https://do:1–17.
3. Senchenkova EY, Russell J, Yildirim A, Granger DN, Gavins FNE. Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II–Induced Microvascular Dysfunction. Hypertension. 2019;73:829–38.
4. Didion SP. Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature. Int J Mol Sci. 2017;18:1–23.
5. Shah N, Sethi R, Shah S, Jafri K, Duran J, Chang Y, et al. The Roles of Platelet-Activating Factor and Magnesium in Pathophysiology of Hypertension, Atherogenesis, Cardiovascular Disease, Stroke and Aging. cardiogenetics. 2022;12:49–62.
6. Gang L, Yanyan Z, Zhongwei Z, Juan D. Association between mean platelet volume and hypertension incidence. Hypertens Res. 2017;40:779–84.
7. Hutapea RD, Widaningsih Y, Mangarengi FDM. Analysis of Urea, Creatinine, and Platelet Indices in Hypertensive Patients. Clin Pathol Med Lab. 2021;27(2):117–21.
8. Najafi MT, Khatami MR, Shojamoradi MH, Fazeli SA, Abbasi MR. Pattern of platelet indices in hypertension: a single-centre experience for a primary care setting. Fam Med Prim Care Rev. 2023;25(3):302–9.
9. Suryana D, Widaningsih Y, Mangarengi F, Muhadi D. Analysis of Platelet Indices and Proteinuria in Primary Hypertensive Patients. Indones J Clin Pathol Med Lab. 2022;28(2):105–10.
10. Sulistiawati S, Dewanti L, Pratama AP, Atika A, Fatmaningrum W, Nuswantoro D, et al. Profile and Lifestyle of Hypertensive Patients, Cardiovascular Comorbidity, and Complications in a Primary Health Center in Surabaya, Indonesia. Maced J Med Sci. 2020;8(E):219–23.
11. Bawazir LA. Profile of Hypertensive Patients in Indonesia National Referral Hospital. eJournal Kedokt Indones. 2019;7(2):91–100.
12. Pogorzelska K, Krętowska A, Krawczuk-Rybak M, Małgorzata S-Ż. Characteristics of platelet indices and their prognostic significance in selected medical condition – a systematic review. Adv Med Sci. 2020;65:310–5.
13. Sachdev R, Tiwari AK, Goel S, Raina V, Sethi M. Establishing biological reference intervals for novel platelet parameters (immature platelet fraction, high immature platelet fraction, platelet distribution width, platelet large cell ratio, platelet-X, plateletcrit, and platelet distribution width) and . I NDIAN J OURNAL O F P ATHOLOGY M ICROBIOLOGY. 2014;57(2):231–5.
14. Pereira KN, Carvalho JAM de, Clóvis P. Reference intervals of the platelet indexes in a healthy population in Santa Maria, Rio Grande do Sul, Brazil. Hematol Transfusion, Cell Ther. 2019;41(2):187–9.
15. Surgit O, Pusuroglu H, Erturk M, Akgul O, Buturak A, Akkaya E, et al. Assessment of Mean Platelet Volume in Patients with Resistant Hypertension, Controlled Hypertension and Normotensives. Euroasian J Med. 2015;47:79–84.
16. Gawlita M, Wasilewski J, Osadnik T, Reguła R, Bujak K, Gonera M. Mean platelet volume and platelet-large cell ratio as prognostic factors for coronary artery disease and myocardial infarction. Folia Cardiol. 2015;10(6):418–22.
17. Shanker S, B NM. Plateletcrit - An important indicator of hypertension induced organ damage. Res J Med Allied Heal Sci. 2020;3(2):1.
18. Said EA, Al-Reesi I, Al-Shizawi N, Jaju S, Al-Balushi MS, Koh CY, et al. Defining IL-6 levels in healthy individuals: A meta-analysis. J Med Virol. 2021;93(6):3915–24.
19. Elsayed AM, Lbrahim WM, Grawesh SA, Elbadawy AM. Study of the Relation between Il-6, Insulin Resistance, and Blood Pressure in Essential Hypertensive Patients. Egypt J Hosp Med. 2022;88:2549–2055.
20. Oluboyo AO, Okoro C., Ekpo V., Oluboyo B. Assessment of interleukins 1 and 6 in hypertensive subjects. Int J Biol Chem Scince. 2019;13(6):2513–20.
21. Tadi S, Mahendran B. Interleukin-6, uric acid, and electrolytes for the detection of endothelial dysfunction in pre-hypertensive and hypertensive patients. Int J Med Sci Public Heal. 2019;8(3):248–54.
22. Zenglei Z, Zhao L, Zhou X, Meng X, Zhou X. Role of Inflamation, immunity, and oxidative stress in hypertension: New insight and potentioal therapeutic targets. Front Immunol. 2023;10(13).
23. Jian Z-W, Zhang X-M, Huang G-S. Clinical Value of the platelet and inflammatory factor activation in vascular endothelial injury in essential hypertension. Clin Hemorheol Microcirc. 2022;83(2).
24. Afsar N, Akhtar I, Afroze, Tahniath H, Abid Z. Role of Mean Platelet Volume As An Adjunct in Evaluation of Acute Inflammation. Ann Pathol Lab Med. 2017;4(4):466–9.
25. Behl T, Kumar V, Singh S, Sahoo R, Sharma N, Singh N. Study of Immature Platelet Fraction, Mean Platelet Volume and Interleukin-6 in Acute Coronary Syndrome: A Study at a Tertiary Care Hospital in India. Indian J Clin Cardiol. 2024;5(2):111–219.
26. Shamsi FS, Soodejani MT. Platelet Indices and Hypertension: Results from Shahedieh Cohort Study, Yazd, Iran. Int J Hypertens. 2024;1(1):1–6.
Published
2025-03-31
How to Cite
ROSLAENI, Rini et al. KORELASI INDEKS PLATELET DAN KADAR INTERLEUKIN-6 PADA PASIEN HIPERTENSI. Medika Kartika : Jurnal Kedokteran dan Kesehatan, [S.l.], v. 8, n. 1, p. 71-81, mar. 2025. ISSN 2655-6537. Available at: <http://medikakartika.unjani.ac.id/medikakartika/index.php/mk/article/view/1272>. Date accessed: 09 may 2025.
Citation Formats
Issue
Vol 8 No 1 (2025): Medika Kartika : Jurnal Kedokteran dan Kesehatan
Section
Articles